JUSTIN PARTIN: Open Payments
NPI 1093281917 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 54 payments from 11 companies in 2025. Trend: 2023 $306 · 2024 $699 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $284 |
| PFIZER INC. | 15 | $206 |
| Amgen Inc. | 7 | $180 |
| Alnylam Pharmaceuticals Inc. | 2 | $119 |
| Medtronic, Inc. | 1 | $106 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| CVRx, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: LEQVIO, VYNDAQEL, REPATHA, AMVUTTRA, AURORA EV-ICD MRI SURESCAN, VERQUVO, Barostim Neo System, ELIQUIS.
Industry payments across AR — which companies pay providers there.
